The White House has issued an executive order that modifies the scope of reciprocal tariffs initially announced in April. This order aims to create a framework for trade agreements with international partners on specific goods, including critical minerals and pharmaceutical products.
The executive order introduces a Potential Tariff Adjustments for Aligned Partners Annex. This annex includes a list of products that President Trump would consider applying the "most favored nation" tariff to, contingent upon future reciprocal trade deals. Among the four product categories listed are pharmaceuticals and their ingredients.
The American Hospital Association is one of the organizations potentially affected by these changes due to its involvement in healthcare and pharmaceuticals.
Information from this article can be found here.
